# ImmusanT

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/immusant

- Industry: Biotechnology
- Headquarters: Cambridge, US
- Website: www.immusant.com
- Total disclosed funding: $20M
- Latest round: Series C (Nov 14, 2017)
- Investors on record: 2

## About

Founded in 2010 and based in Massachusetts, US, ImmusanT, Inc. is a biotechnology company that focuses on developing therapies for the treatment of celiac disease.

## Funding rounds

- Series C, Nov 14, 2017, $20M — ARCH Venture Partners, Vatera Healthcare Partners

## Investors

- ARCH Venture Partners (https://capitalatlas.ai/funds/arch-venture-partners) — Series C
- Vatera Healthcare Partners — Series C